1-20 of 32
Wei Qiao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Addition of Inotuzumab Ozogamicin to Melphalan Plus Fludarabine Reduced-Intensity Conditioning Regimen of Allogeneic Transplantation in Patients with Acute Lymphoblastic Leukemia and Aggressive Lymphoid Malignancies: A Phase II Prospective Trial

Issa F. Khouri, Hagop M. Kantarjian, Alison M. Gulbis, Manuel M. Christopher, Fadi G. Haddad, Hussein A. Abbas, Bofei Wang, Koji Sasaki, Nitin Jain, Tapan M. Kadia, David Marin, Elizabeth J. Shpall, Gabriela Rondon, Hind Rafei, Jeremy Ramdial, Jin S. Im, Partow Kebriaei, Wei Qiao, Richard E. Champlin, Elias Jabbour
Journal: Blood
Blood (2024) 144 (Supplement 1): 2124.
https://doi.org/10.1182/blood-2024-203864
Published: 2024
Journal Articles

Early Obinutuzumab Significantly Increases Bone Marrow Undetectable MRD (10 -4 sensitivity) (uMRD4) Rate When Combined with Acalabrutinib and Venetoclax in a Randomized Phase II Trial for Treatment Naïve CLL

Mahesh Swaminathan, Philip A. Thompson, Jan A. Burger, Musa Yilmaz, Nitin Jain, Tapan M. Kadia, Lucia Masarova, Yesid Alvarado Valero, Prithviraj Bose, Alessandra Ferrajoli, Ghayas C. Issa, Steven M. Kornblau, Farhad Ravandi, Koji Sasaki, Gautam Borthakur, Kelly S. Chien, Courtney D. DiNardo, Danielle Hammond, Elias Jabbour, Guillermo Montalban-Bravo, Naveen Pemmaraju, Nicholas J. Short, Koichi Takahashi, Francesco Paolo Tambaro, Wei Qiao, Naveen Garg, Michael J. Keating, William G. Wierda
Journal: Blood
Blood (2024) 144 (Supplement 1): 1855.
https://doi.org/10.1182/blood-2024-211110
Published: 2024
Journal Articles

Combined Pirtobrutinib, Venetoclax, and Obinutuzumab As First-Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)

Nitin Jain, Alessandra Ferrajoli, Mahesh Swaminathan, Patrick K. Reville, Jan A. Burger, Vanthana Bharathi, Himachandana Atluri, Hua-Jay J Cherng, Alex Bataller, Elias Jabbour, Tapan M. Kadia, Gautam Borthakur, Koichi Takahashi, Kelly S. Chien, Musa Yilmaz, Naveen Pemmaraju, Naval Daver, Fadi G. Haddad, Yesid Alvarado Valero, Jo Ishizawa, Guillermo Montalban-Bravo, Naveen Garg, Hyunsoo Hwang, Wei Qiao, Cameron Garcia, Anna Evangelio, Ana Ayala, Deepa Sampath, Varsha Gandhi, Michael J. Keating, Hagop M. Kantarjian, William G. Wierda
Journal: Blood
Blood (2024) 144 (Supplement 1): 1011.
https://doi.org/10.1182/blood-2024-211454
Published: 2024
Journal Articles

Results of Phase I/II Study of Azacitidine in Combination with Quizartinib for Patients with Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms with FLT3 or CBL Mutations

Guillermo Montalban-Bravo, Elias Jabbour, Kelly S. Chien, Danielle E. Hammond, Nicholas J. Short, Farhad Ravandi, Marina Y. Konopleva, Gautam Borthakur, Naval Daver, Rashmi Kanagal-Shamanna, Wei Qiao, Xuelin Huang, Heather Schneider, Meghan Anne Meyer, Hagop M. Kantarjian, Guillermo Garcia-Manero
Journal: Blood
Blood (2023) 142 (Supplement 1): 3238.
https://doi.org/10.1182/blood-2023-178115
Published: 2023
Journal Articles

Oral Decitabine/Cedazuridine with Venetoclax in High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia: Analysis By Different Response Criteria

Alex Bataller, Guillermo Montalban-Bravo, Alexandre Bazinet, Yesid Alvarado Valero, Kelly S. Chien, Sangeetha Venugopal, Jo Ishizawa, Danielle E. Hammond, Mahesh Swaminathan, Koji Sasaki, Ghayas C. Issa, Nicholas J. Short, Lucia Masarova, Naval Daver, Tapan M. Kadia, Simona Colla, Wei Qiao, Xuelin Huang, Rashmi Kanagal-Shamanna, Stephany Hendrickson, Farhad Ravandi, Elias Jabbour, Hagop Kantarjian, Guillermo Garcia-Manero
Journal: Blood
Blood (2023) 142 (Supplement 1): 3228.
https://doi.org/10.1182/blood-2023-189203
Published: 2023
Journal Articles

Ten-Day Decitabine with Venetoclax (DEC10-VEN) in Acute Myeloid Leukemia and Myelodysplastic Syndrome: Updated Results of a Phase II Trial

Abhishek Maiti, Courtney D. DiNardo, Caitlin R. Rausch, Naveen Pemmaraju, Guillermo Garcia-Manero, Maro Ohanian, Naval Daver, Ghayas C. Issa, Gautam Borthakur, Farhad Ravandi, Yesid Alvarado, Tapan M. Kadia, Nicholas J. Short, Elias J. Jabbour, Guillermo Montalban-Bravo, Nitin Jain, Steven M. Kornblau, Lucia Masarova, William G. Wierda, Koji Sasaki, Koichi Takahashi, Musa Yilmaz, Jan A. Burger, Zeev E. Estrov, Srdan Verstovsek, Michael Andreeff, Prithviraj Bose, Alessandra Ferrajoli, Philip A. Thompson, Kathryn Montalbano, Kenneth Vaughan, Carol A. Bivins, Sherry A. Pierce, Wei Qiao, Jing Ning, John Welch, Hagop Kantarjian, Marina Konopleva
Journal: Blood
Blood (2021) 138 (Supplement 1): 1270.
https://doi.org/10.1182/blood-2021-153530
Published: 2021
Journal Articles

A Triplet Combination of Azacitidine, Venetoclax and Gilteritinib for Patients with FLT3 -Mutated Acute Myeloid Leukemia: Results from a Phase I/II Study

Nicholas J. Short, Courtney D. DiNardo, Naval Daver, Daniel Nguyen, Musa Yilmaz, Tapan M. Kadia, Guillermo Garcia-Manero, Ghayas C. Issa, Xuelin Huang, Wei Qiao, Koji Sasaki, Guillermo Montalban-Bravo, Kelly S. Chien, Gautam Borthakur, Ricardo Delumpa, Anna Milton, Sherry A. Pierce, Elias J. Jabbour, Marina Konopleva, Hagop Kantarjian, Farhad Ravandi
Journal: Blood
Blood (2021) 138 (Supplement 1): 696.
https://doi.org/10.1182/blood-2021-153571
Published: 2021
Journal Articles

Phase II Trial of Ten-Day Decitabine with Venetoclax (DEC10-VEN) in Acute Myeloid Leukemia: Updated Outcomes in Genomic Subgroups

Abhishek Maiti, Courtney D. DiNardo, Caitlin R. Rausch, Naveen Pemmaraju, Guillermo Garcia-Manero, Maro Ohanian, Naval Daver, Ghayas C. Issa, Gautam Borthakur, Farhad Ravandi, Yesid Alvarado, Tapan M. Kadia, Elias J. Jabbour, Nicholas J. Short, Guillermo Montalban-Bravo, Nitin Jain, Steven M. Kornblau, Lucia Masarova, William G. Wierda, Koji Sasaki, Koichi Takahashi, Musa Yilmaz, Jan A. Burger, Zeev E. Estrov, Srdan Verstovsek, Michael Andreeff, Prithviraj Bose, Alessandra Ferrajoli, Philip A. Thompson, Kathryn Montalbano, Kenneth Vaughan, Carol A. Bivins, Sherry A. Pierce, Wei Qiao, Jing Ning, John S. Welch, Hagop Kantarjian, Marina Konopleva
Journal: Blood
Blood (2021) 138 (Supplement 1): 694.
https://doi.org/10.1182/blood-2021-153227
Published: 2021
Journal Articles

Phase 1 Results of Novel Combination Therapy: BET Inhibitor PLX51107 with Azacitidine in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Naveen Pemmaraju, Kapil N. Bhalla, Naval Daver, Nathaniel R Wilson, Warren C. Fiskus, Farhad Ravandi, Guillermo Garcia-Manero, Tapan M. Kadia, Courtney D. DiNardo, Elias J. Jabbour, Jan A. Burger, Nicholas J. Short, Yesid Alvarado, Nitin Jain, Lucia Masarova, Srdan Verstovsek, Ghayas C. Issa, Wei Qiao, Joseph D. Khoury, Sherry A. Pierce, Darla Miller, Marina Konopleva, Hagop Kantarjian, Gautam Borthakur
Journal: Blood
Blood (2021) 138 (Supplement 1): 3421.
https://doi.org/10.1182/blood-2021-154351
Published: 2021
Journal Articles

Phase II Study of CPX-351 Plus Venetoclax in Patients with Acute Myeloid Leukemia (AML)

Tapan M. Kadia, MD, Gautam Borthakur, MD, Koichi Takahashi, MD PhD, Courtney D. DiNardo, MD MSCE, Naval Daver, MD, Naveen Pemmaraju, MD, Elias Jabbour, MD, Nitin Jain, MD, Nicholas J. Short, MD, Wei Qiao, PhD, Lade Adewale, Caitlin R. Rausch, PharmD, Sherry A. Pierce, BSN, BA, Yesid Alvarado, MD, Amin M. Alousi, MD, Uday R. Popat, MD, Issa F. Khouri, MD, Guillermo Garcia-Manero, MD, Marina Konopleva, MD PhD, Jorge E. Cortes, MD, Farhad Ravandi, MBBS, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–22.
https://doi.org/10.1182/blood-2020-142074
Published: 2020
Journal Articles

Outcomes of Relapsed or Refractory Acute Myeloid Leukemia after Frontline Hypomethylating Agent with Venetoclax Regimens

Abhishek Maiti, MBBS, Caitlin R. Rausch, PharmD, Jorge E. Cortes, MD, Naveen Pemmaraju, MD, Naval G. Daver, MD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Gautam M. Borthakur, MD, Kiran Naqvi, MDMPH, Maro Ohanian, DO, Nicholas J. Short, MD, Yesid Alvarado, MD, Christopher B. Benton, MD, Christopher B. Benton, MD, Tapan M. Kadia, MD, Koichi Takahashi, MD, Musa E. Yilmaz, MD, Nitin Jain, MD, Steven M. Kornblau, MD, Guillermo Montalban Bravo, MD, Koji Sasaki, MD, Michael Andreeff, MD PhD, Prithviraj Bose, MD, Alessandra Ferrajoli, MD, Ghayas C. Issa, MD, Elias Jabbour, MD, Lucia Masarova, MD, Michael E. Rytting, MD, Philip A. Thompson, MBBS, Sa A Wang, MD, Sergej Konoplev, Zhining Chen, Maitrayee Goswami, Rita Maduike, Julio A Guerrero, RN, Qi Zhang, PhD, Antonio Cavazos, Helen Ma, MS, Carol A. Bivins, RN, Allison Wade, Shadiat L Adewale, Susan Tse, Robin Thomas, Kenneth Vaughan, RN, Sherry A. Pierce, BSN, BA, Jing Ning, PhD, Wei Qiao, PhD, John S. Welch, MD PhD, Hagop M. Kantarjian, MD, Marina Y Konopleva, MD PhD, Courtney D. DiNardo, MD MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 738.
https://doi.org/10.1182/blood-2019-128909
Published: 2019
Journal Articles

Ten-Day Decitabine with Venetoclax (DEC10-VEN) in Acute Myeloid Leukemia: Updated Results of a Phase II Trial

Abhishek Maiti, MBBS, Courtney D. DiNardo, MDMSc, Caitlin R. Rausch, PharmD, Jorge E. Cortes, MD, Naveen Pemmaraju, MD, Naval G. Daver, MD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Gautam M. Borthakur, MD, Kiran Naqvi, MDMPH, Maro N. Ohanian, DO, Nicholas J. Short, MD, Yesid Alvarado, MD, Christopher B. Benton, MD, Tapan M. Kadia, MD, Koichi Takahashi, MD, Musa E. Yilmaz, MD, Nitin Jain, MD, Steven M. Kornblau, MD, Koji Sasaki, MD, Michael Andreeff, MD PhD, Prithviraj Bose, MD, Alessandra Ferrajoli, MD, Ghayas C. Issa, MD, Elias Jabbour, MD, Lucia Masarova, MD, Michael E. Rytting, MD, Philip A. Thompson, MBBS, Sa A Wang, MD, Sergej Konoplev, Zhining Chen, Maitrayee Goswami, Rita Maduike, Julio A Guerrero, RN, Qi Zhang, PhD, Antonio Cavazos, Helen Ma, MS, Carol A. Bivins, RN, Allison Wade, Shadiat L Adewale, Susan Tse, Robin Thomas, Kenneth Vaughan, RN, Sherry A. Pierce, BSN, BA, Jing Ning, PhD, Wei Qiao, PhD, John S. Welch, MD PhD, Hagop M. Kantarjian, MD, Marina Y Konopleva, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2637.
https://doi.org/10.1182/blood-2019-127803
Published: 2019
Journal Articles

Outcomes in Molecular Subgroups and Resistance Patterns with Ten-Day Decitabine and Venetoclax (DEC10-VEN) in Acute Myeloid Leukemia

Abhishek Maiti, MBBS, Caitlin R. Rausch, PharmD, Jorge E. Cortes, MD, Naveen Pemmaraju, MD, Naval G. Daver, MD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Gautam M. Borthakur, MD, Kiran Naqvi, MDMPH, Maro Ohanian, DO, Nicholas J. Short, MD, Yesid Alvarado, MD, Christopher B. Benton, MD, Tapan M. Kadia, MD, Koichi Takahashi, MD, Musa Yilmaz, MD, Nitin Jain, MD, Steven M. Kornblau, MD, Koji Sasaki, MD, Michael Andreeff, MD PhD, Prithviraj Bose, MD, Alessandra Ferrajoli, MD, Ghayas C. Issa, MD, Elias Jabbour, MD, Lucia Masarova, MD, Michael E. Rytting, MD, Philip A. Thompson, MBBS, Sa A Wang, MD, Sergej Konoplev, Zhining Chen, Maitrayee Goswami, Rita Maduike, Julio A Guerrero, RN, Qi Zhang, PhD, Antonio Cavazos, Helen Ma, MS, Carol A. Bivins, RN, Allison Wade, Shadiat L Adewale, Susan Tse, Robin Thomas, Kenneth Vaughan, RN, Sherry A. Pierce, BSN, BA, Jing Ning, PhD, Wei Qiao, PhD, John S. Welch, MD PhD, Keyur P. Patel, MBBS, PhD, Hagop M. Kantarjian, MD, Marina Y Konopleva, MD PhD, Courtney D. DiNardo, MD MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 645.
https://doi.org/10.1182/blood-2019-128547
Published: 2019
Journal Articles

Myeloproliferative Neoplasm (MPN) Patient Online Questionnaire: Assessing Patients' Disease Knowledge in a Rare Hematologic Malignancy in the Modern Digital Information Era

Naveen Pemmaraju, MD, Theresa Clementi, Wei Qiao, PhD, Susan K Peterson, PhD, Vicky Zoeller, Andrew J. Schorr, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1670.
https://doi.org/10.1182/blood-2019-129545
Published: 2019
Journal Articles

Interim Analysis of Phase II Study of Venetoclax with 10-Day Decitabine (DEC10-VEN) in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Abhishek Maiti, MBBS, Courtney D. DiNardo, MDMSc, Jorge E. Cortes, MD, Gautam Borthakur, MD, Naveen Pemmaraju, MD, Christopher B. Benton, MD, Tapan M. Kadia, MD, Koichi Takahashi, MD, Kiran Naqvi, MDMPH, Farhad Ravandi, MD, Yesid Alvarado, MD, Nicholas J Short, MD, Naval G. Daver, MD, Koji Sasaki, MD, Maro N. Ohanian, DO, Guillermo Garcia-Manero, MD, Philip A. Thompson, MBBS, Steven M. Kornblau, MD, Lucia Masarova, MD, Nitin Jain, MD, Elias J. Jabbour, MD, Michael Andreeff, MD PhD, Rita Maduike, Julio A Guerrero, RN, Qi Zhang, PhD, Antonio Cavazos, MSc, Helen Ma, MS, Caitlin R. Rausch, PharmD, Carol A. Bivins, RN, Kenneth Vaughan, RN, Sherry A. Pierce, BSN, BA, Jing Ning, PhD, Wei Qiao, PhD, John S. Welch, MD PhD, Hagop M. Kantarjian, MD, Marina Y. Konopleva, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 286.
https://doi.org/10.1182/blood-2018-99-113749
Published: 2018
Journal Articles

Predictors of Outcomes in Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia at First Relapse in the Era of Tyrosine Kinase Inhibitors

Iman Aboudalle, MD, Hagop M. Kantarjian, MD, Nicholas J Short, MD, Marina Y. Konopleva, MD PhD, Nitin Jain, MD, Guillermo Garcia-Manero, MD, Rebecca E. Garris, MSc, Wei Qiao, PhD, Jorge E. Cortes, MD, Susan M. O'Brien, MD, Partow Kebriaei, MD, Tapan M. Kadia, MD, Elias J. Jabbour, MD, Farhad Ravandi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2659.
https://doi.org/10.1182/blood-2018-99-117579
Published: 2018
Journal Articles

Isavuconazole (ISAV) As Primary Anti-Fungal Prophylaxis in Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-Label, Prospective Study

Prithviraj Bose, MD, David McCue, Nathan P. Wiederhold, PharmD, Tapan M. Kadia, MD, Gautam Borthakur, MD, Farhad Ravandi, MD, Musa Yilmaz, MD, Koichi Takahashi, MD, Philip A. Thompson, MBBS, Naveen Pemmaraju, MD, Naval G. Daver, MD, Jan A. Burger, MD PhD, Jorge E. Cortes, MD, Guillermo Garcia-Manero, MD, Srdan Verstovsek, MD PhD, Marina Y. Konopleva, MD PhD, Nitin Jain, MD, Courtney D. DiNardo, MD MSc, Yesid Alvarado, MD, Kiran Naqvi, MD MPH, Steven M. Kornblau, MD, Alessandra Ferrajoli, MD, William G. Wierda, MD PhD, Zeev E. Estrov, MD, Christopher B. Benton, MD, Lucia Masarova, MD, Guillermo Montalban-Bravo, MD, Koji Sasaki, MD, Caitlin R. Rausch, PharmD, Kayleigh Marx, PharmD, Wei Qiao, PhD, Xuelin Huang, PhD, Carol A. Bivins, RN, Sherry A. Pierce, BSN, BA, Hagop M. Kantarjian, MD, Dimitrios P. Kontoyiannis, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2674.
https://doi.org/10.1182/blood-2018-99-111727
Published: 2018
Journal Articles

Five-Day Versus Ten-Day Schedules of Decitabine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase II Study

Nicholas J Short, MD, Hagop M. Kantarjian, MD, Sanam Loghavi, MD, Xuelin Huang, PhD, Wei Qiao, PhD, Gautam Borthakur, MD, Tapan M. Kadia, MD, Naval G. Daver, MD, Maro N. Ohanian, DO, Courtney D. DiNardo, MDMSc, Zeev E. Estrov, MD, Rashmi Kanagal-Shamanna, MD, Abhishek Maiti, MBBS, Christopher B. Benton, MD, Prithviraj Bose, MD, Yesid Alvarado, MD, Elias J. Jabbour, MD, Steven M. Kornblau, MD, Naveen Pemmaraju, MD, Nitin Jain, MD, Yvonne Gasior, RN, Mary Ann Richie, Sherry A. Pierce, BSN, BA, Jorge E. Cortes, MD, Marina Y. Konopleva, MD PhD, Guillermo Garcia-Manero, MD, Farhad Ravandi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 84.
https://doi.org/10.1182/blood-2018-99-115367
Published: 2018
Journal Articles

A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia

Clinical Trials & Observations
Lisa S. Chen, Prithviraj Bose, Nichole D. Cruz, Yongying Jiang, Qi Wu, Philip A. Thompson, Shuju Feng, Michael H. Kroll, Wei Qiao, Xuelin Huang, Nitin Jain, William G. Wierda, Michael J. Keating, Varsha Gandhi
Journal: Blood
Blood (2018) 132 (21): 2249–2259.
https://doi.org/10.1182/blood-2018-06-860593
Published: 2018
Includes: Supplemental data
Journal Articles

Pneumocystis Jiroveci Pneunomia Prophylaxis during Maintenance Therapy with Hyper-CVAD Regimens for Adult Acute Lymphoblastic Leukemia

Grace A. Martin, PharmD, Shilpa Paul, PharmD, Wei Qiao, PhD, Elias J. Jabbour, MD, Dimitrios P. Kontoyiannis, MD, Deborah A. McCue, PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1295.
https://doi.org/10.1182/blood.V130.Suppl_1.1295.1295
Published: 2017